Pharmaceutical soft capsules containing lysine clonixinate...

Details Pharmaceutical soft capsules containing lysine clonixinate... Pharmaceutical soft capsules containing lysine clonixinate...

A - Human Necessities

61

K

A61K 31/455 (2006.01) A61K 9/48 (2006.01) A61K 47/10 (2006.01) A61K 47/34 (2006.01)

Patent

CA 2098410

Title: Pharmaceutical soft capsules containing lysine clonixinate and a process for their preparation. Abstract: Soft gelatin capsules with a filling comprising lysine clonixinate as active ingredient in a hydrophilic matrix. The capsules according to the present invention exhibit a good shelf live and a more rapid therapeutic onset upon oral administration. The hydrophilic matrix comprises polyethylene glycol with an average molecular weight of about 200 to 1000, or a mixture of said polyethylene glycol with propylene glycol and/or propylene carbonate, 3 to 10% by weight glycerol and 5 to 15% by weight water. The soft gelatine capsules may be utilized in the treatment of pain or inflammatory conditions.

Affiliated with

Also associated with

Rating

Pharmaceutical soft capsules containing lysine clonixinate... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical soft capsules containing lysine clonixinate..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical soft capsules containing lysine clonixinate... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1498539